FDA will actively regulate only the small portion of mobile medical applications that present the same risks as conventional FDA-regulated devices, the agency affirmed in the much-anticipated mobile apps final guidance issued Sept. 23.
Sticking to a policy outlined in its 2011 draft guidance, the agency will apply enforcement discretion to a long list of lower-risk app types, even if they might technically meet...